Mareo como forma de presentación de insulinoma maligno en un paciente anciano | Revista Española de Geriatría y Gerontología

Información del artículo

Resumen

Los mareos son muy frecuentes en pacientes geriátricos, pero se trata de una clínica vaga y poco precisa que puede presentarse en muchas y variadas enfermedades. Presentamos un caso clínico de un paciente de 83 años con mareos como clínica inicial y posteriormente estudiado por hipoglucemias, al que se le descubrió un insulinoma maligno, muy poco habitual en estas edades. Se revisan la discusión, los procedimientos diagnósticos, el manejo y los tratamientos del insulinoma maligno.

Palabras clave:

Insulinoma maligno

Mareo

Insulinoma

Abstract

Dizziness is frequent in the elderly, but the symptom is vague and can be present in several diseases. We describe the case of an 83-year-old man who presented with dizziness. Investigation of subsequent hypoglycaemia revealed a malignant insulinoma. This entity is unusual in the elderly. We discuss the diagnostic procedures, management and treatment of malignant insulinoma.

Key words:

Malignant insulinoma

Dizziness

Insulinoma

El Texto completo está disponible en PDF

Bibliografía

[1.]

F.J. Service, M.M. McMahon, P.C. O'Brien.

Function insulinoma: incidence, recurrence and long term survival of patients: a 60 year study.

Mayo Clin Proc, 66 (1991), pp. 711-719

Medline

[2.]

F.J. Service.

Classification of hypoglycemic disorders.

Endocrinol Metab Clin North Am, 28 (1999), pp. 501-517

Medline

[3.]

V. Marks, J. Derrick Teale.

Drug induced hypoglucemia.

Endocrinol Metab Clin North Am, 28 (1999), pp. 555-577

Medline

[4.]

R.J. Comi, P. Gorden.

Hypoglycemic disorders in the adult.

Principles and practice of endocrinology and metabolism, pp. 2884-2887

[5.]

B. Hirshhberg, A. Livi, D.L. Bartelett.

Forty-eight-hour fast: the diagnostic test for insulinoma.

J Clin Endocrinol Metab, 85 (2000), pp. 3222-3226

http://dx.doi.org/10.1210/jcem.85.9.6807 | Medline

[6.]

F.J. Service, P.C. O'Brien, M. Molly.

C-peptide during the prolonged fast in insulinoma.

J Clin Endocrinol Metab, 76 (1993), pp. 655-659

http://dx.doi.org/10.1210/jcem.76.3.8445021 | Medline

[7.]

S. Sheth, R.K. Hruban.

Helical TC of islet cell tumors of the pancreas: typical and atypical manifestation.

AJR, 179 (2002), pp. 725-730

http://dx.doi.org/10.2214/ajr.179.3.1790725 | Medline

[8.]

P. Pavonne, D.G. Mitchell, F. Leonetti.

Pancreatic beta cell tumors: MRI.

J Comput Assist Tomogr, 17 (1993), pp. 403-407

Medline

[9.]

Y. Oda, Y. Tanaka, T. Naruse.

Expression of somatostatine receptor and effects of somatostatine analogs on pancreatic endocrine tumors.

Surg Today, 32 (2002), pp. 690-694

http://dx.doi.org/10.1007/s005950200128 | Medline

[10.]

C.H.J. Van Eyck, H.A. Bruining, J.C. Reubi.

Use of isotope labeled somatostatin analogs for visualization of islets cells tumors.

World J Surg, 17 (1993), pp. 444-448

Medline

[11.]

M.A. De Jong, R. Valkema, F. Jamar, et al.

Somatostin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.

Seminar Nucl Med, 2 (2002), pp. 133-140

[12.]

J. Pitre, O. Soubrane, L. Palazzo, Y. Chapuis.

Endoscopic ultrasonography for the preoperative localization of insulinomas.

Pancreas, 13 (1996), pp. 55-60

Medline

[13.]

L.o. Chung Yau, Chan Fu Luk, S.C. Tam.

Value of intra-arterial calcium stimulated venous sampling for regionalization of pancreatic insulinomas.

Surgery, 128 (2000), pp. 903-909

http://dx.doi.org/10.1067/msy.2000.109729 | Medline

[14.]

L.A. Hashimoto, R.M. Walsh.

Preoperative localization of insulinomas is not necessary.

J Am Coll Surg, 189 (1999), pp. 368-373

Medline

[15.]

F.J. Berends, M.A. Cuesta, G. Kazamier.

Laparoscopic detection and resection of insulinomas.

Surgery, 128 (2000), pp. 386-391

http://dx.doi.org/10.1067/msy.2000.107413 | Medline

[16.]

D. Mahon, E. Allen, M. Rhodes.

Laparoscopic distal pancreatectomy.

Surg Endoscopic, 16 (2002), pp. 700-702

[17.]

B. Hirshberg, S.K. Libutti, et al.

Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure.

J Am Coll Surg, 194 (2002), pp. 761-764

Medline

[18.]

M.Q.F. Hatton, N.S. Reed.

Chemotherapy for neuroendocrine tumors: The Beatson Oncology Center experience.

Clinical Oncology, 9 (1997), pp. 385-389

Medline

[19.]

G.V. Gill, O. Rauf, I.A. Mac Farlane.

Dioxide treatment for insulinoma: a national UK survey.

Postgrad Med J, 73 (1997), pp. 640-641

Medline

[20.]

M. Civera Andrés, J.T. Real Collado.

Embolización terapéutica selectiva en el insulinoma maligno.

Rev Clin Esp, 200 (2000), pp. 548-550

Medline

Indexada en:

Síguenos:

Suscribirse:

Indexada en:

Síguenos:

Suscribirse:

Suscríbase a la newsletter